Calidi Biotherapeutics Announces Closing of $6.9 Million Underwritten Public Offering and Full Exercise of Underwriters Over-Allotment Option
SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE…
Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering
June 26, 2025 23:43 ET | Source: Achieve Life Sciences SEATTLE and…
